Abiopharma

Stacherski Kenneth R. acquired 10.2k shares of GE HealthCare Technologies Inc. (GEHC) Filed: 2025-08-19 AccNo: 0001889865-25-000006 Size: 5 KB

New Form 8-K - PTC THERAPEUTICS, INC. Filed: 2025-08-19 AccNo: 0001558370-25-011658 Size: 192 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 8-K - Rein Therapeutics, Inc. Filed: 2025-08-19 AccNo: 0001193125-25-183073 Size: 152 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

Silo Pharma Notification (SILO)

Butterfly Network, Inc. - Butterfly Network Joins Research Project Studying the Impact of AI-Assisted POCUS on Early Tuberculosis Detection in Sub-Saharan Africa

Silo Pharma’s PTSD Candidate SPC-15 Achieves Positive Safety Milestone, Paving Way for Accelerated Clinical Trials Under 505(b)(2) Pathway

PTC Therapeutics Receives Complete Response Letter for Vatiquinone NDA

iBio Announces Pricing of $50 Million Public Offering

New Form DEFA14A - ProPhase Labs, Inc. Filed: 2025-08-19 AccNo: 0001641172-25-024733 Size: 90 KB

Twist Bioscience Launches Oncology DNA CGP Panel to Advance Precision Medicine with Customizable, Platform-Agnostic NGS Solution

Milestone® Pharmaceuticals to Present at Upcoming Conferences

Incyte to Present at Upcoming Investor Conferences

Quantum-Si to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

New Form 8-K - MIRA PHARMACEUTICALS, INC. Filed: 2025-08-19 AccNo: 0001641172-25-024731 Size: 207 KB Item 8.01: Other Events

New Form 8-K - Akari Therapeutics Plc Filed: 2025-08-19 AccNo: 0001641172-25-024732 Size: 7 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits